Sorafenat is a prescription medication manufactured by Natco Pharma Ltd, primarily used in the treatment of certain types of cancer. Sorafenat belongs to the class of anti-cancer medications, specifically categorized as multikinase inhibitors. These drugs work by blocking abnormal proteins that signal cancer cells to multiply, thereby helping to stop or slow the spread of cancer cells.
Category | Anti Cancer Drugs |
Brand | Natco |
Ingredient | Sorafenib |
Prescription Required | Yes |
Strength | — |
Package | 120 Tablets |
Sorafenat, which contains the active ingredient Sorafenib, works by targeting and inhibiting multiple protein kinases that are involved in the growth and spread of cancer cells. Specifically, Sorafenib blocks enzymes that control both tumor cell proliferation (growth) and angiogenesis—the process through which tumors develop new blood vessels to supply themselves with oxygen and nutrients.
Sorafenat offers significant benefits for patients with advanced or difficult-to-treat cancers. By inhibiting multiple kinases involved in both tumor growth and the formation of new blood vessels, Sorafenat effectively slows down the progression of cancers such as renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and differentiated thyroid cancer.
The most common side effects of Sorafenat are
• Fatigue (tiredness)
• Diarrhea
• Skin rash or peeling (especially on the palms and soles)
• High blood pressure (hypertension)
• Loss of appetite
• Weight loss
• Mouth sores (stomatitis)
• Nausea and vomiting
• Hair thinning or hair loss
• Abdominal pain
Other side effects of Sorafenat include
• Liver problems (e.g., liver failure or severe liver damage)
• Severe bleeding (e.g., gastrointestinal bleeding, nosebleeds, or blood in the urine)
• Heart problems (e.g., heart attack, chest pain, or irregular heartbeat)
• Gastrointestinal perforation (hole in the stomach or intestinal wall)
• Severe skin reactions (e.g., blistering or peeling of the skin)
• High fever or infections (due to weakened immune response)
• Thyroid problems (e.g., hypothyroidism or hyperthyroidism)
• High blood sugar (hyperglycemia)
• Kidney problems (e.g., kidney failure)
• Severe fatigue or weakness
Sorafenat should not be taken by individuals who are allergic to Sorafenib or any of its components, as this could lead to severe allergic reactions. It is also not recommended for pregnant or breastfeeding women because Sorafenat can cause harm to the fetus or infant. Patients with severe liver disease or active liver dysfunction should avoid using Sorafenat, as it can worsen liver function and may lead to liver failure.
Sorafenat should be taken exactly as prescribed by a healthcare provider. The usual dosage is 400 mg (two 200 mg tablets) taken twice a day with a low-fat meal to reduce the risk of stomach upset. It is important to take the tablets at approximately the same times each day to maintain consistent levels of the medication in the body. Do not crush, chew, or break the tablets—they should be swallowed whole with a glass of water.
There are no reviews yet.